Literature DB >> 19648538

Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action.

Catherine J Harmer1, Guy M Goodwin, Philip J Cowen.   

Abstract

BACKGROUND: The neuropharmacological actions of antidepressants are well characterised but our understanding of how these changes translate into improved mood are still emerging. AIMS: To investigate whether actions of antidepressant drugs on emotional processing are a mediating factor in the effects of these drugs in depression.
METHOD: We examined key published findings that explored the effects of antidepressants on behavioural and functional magnetic resonance imaging (fMRI) measures of emotional processing.
RESULTS: Negative emotional bias has been reliably associated with depression. Converging results suggest that antidepressants modulate emotional processing and increase positive emotional processing much earlier than effects on mood. These changes in emotional processing are associated with neural modulation in limbic and prefrontal circuitry.
CONCLUSIONS: Antidepressants may work in a manner consistent with cognitive theories of depression. Antidepressants do not act as direct mood enhancers but rather change the relative balance of positive to negative emotional processing, providing a platform for subsequent cognitive and psychological reconsolidation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648538     DOI: 10.1192/bjp.bp.108.051193

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  146 in total

1.  Mood Homeostasis, Low Mood, and History of Depression in 2 Large Population Samples.

Authors:  Maxime Taquet; Jordi Quoidbach; James J Gross; Kate E A Saunders; Guy M Goodwin
Journal:  JAMA Psychiatry       Date:  2020-09-01       Impact factor: 21.596

2.  Serotonin selectively modulates reward value in human decision-making.

Authors:  Ben Seymour; Nathaniel D Daw; Jonathan P Roiser; Peter Dayan; Ray Dolan
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

3.  Impact of escitalopram on vagally mediated cardiovascular function in healthy participants: implications for understanding differential age-related, treatment emergent effects.

Authors:  Andrew H Kemp; Tim Outhred; Sasha Saunders; Andre R Brunoni; Pradeep J Nathan; Gin S Malhi
Journal:  Psychopharmacology (Berl)       Date:  2013-12-15       Impact factor: 4.530

4.  Magnetic resonance imaging predictors of treatment response in late-life depression.

Authors:  Howard J Aizenstein; Alexander Khalaf; Sarah E Walker; Carmen Andreescu
Journal:  J Geriatr Psychiatry Neurol       Date:  2013-12-30       Impact factor: 2.680

Review 5.  Possible role of more positive social behaviour in the clinical effect of antidepressant drugs.

Authors:  Simon N Young; Debbie S Moskowitz; Marije aan het Rot
Journal:  J Psychiatry Neurosci       Date:  2014-01       Impact factor: 6.186

6.  The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.

Authors:  Jacob P R Jacobsen; Per Plenge; Benjamin D Sachs; Alan L Pehrson; Manuel Cajina; Yunzhi Du; Wendy Roberts; Meghan L Rudder; Prachiti Dalvi; Taylor J Robinson; Sharon P O'Neill; King S Khoo; Connie Sanchez Morillo; Xiaodong Zhang; Marc G Caron
Journal:  Psychopharmacology (Berl)       Date:  2014-05-09       Impact factor: 4.530

7.  Effects of subcallosal cingulate deep brain stimulation on negative self-bias in patients with treatment-resistant depression.

Authors:  Matthew R Hilimire; Helen S Mayberg; Paul E Holtzheimer; James M Broadway; Nathan A Parks; Jordan E DeVylder; Paul M Corballis
Journal:  Brain Stimul       Date:  2014-11-24       Impact factor: 8.955

8.  The role of serotonin in the neurocircuitry of negative affective bias: serotonergic modulation of the dorsal medial prefrontal-amygdala 'aversive amplification' circuit.

Authors:  Oliver J Robinson; Cassie Overstreet; Philip S Allen; Alison Letkiewicz; Katherine Vytal; Daniel S Pine; Christian Grillon
Journal:  Neuroimage       Date:  2013-04-11       Impact factor: 6.556

9.  Information processing bias and pharmacotherapy outcome in older adults with generalized anxiety disorder.

Authors:  Amanda R W Steiner; Andrew J Petkus; Hoang Nguyen; Julie Loebach Wetherell
Journal:  J Anxiety Disord       Date:  2012-11-21

10.  Catechol-O-methyltransferase val158met genotype determines effect of reboxetine on emotional memory in healthy male volunteers.

Authors:  Ayana A Gibbs; Carla E Bautista; Florence D Mowlem; Kris H Naudts; Dora T Duka
Journal:  J Psychiatry Neurosci       Date:  2014-05       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.